🇯🇵 Repatha in Japan

PMDA authorised Repatha on 22 January 2016

Marketing authorisation

PMDA — authorised 22 January 2016

  • Marketing authorisation holder: Astellas Pharma
  • Status: approved

Repatha in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in Japan

Frequently asked questions

Is Repatha approved in Japan?

Yes. PMDA authorised it on 22 January 2016.

Who is the marketing authorisation holder for Repatha in Japan?

Astellas Pharma holds the Japanese marketing authorisation.